SP
Starpharma Holdings Limited
SPHRY · OTC
$5.22 -0.38% (-$0.02)
1M +7.41%
Market Cap $308.8M
P/E Ratio -
Div. Yield 1.29%
ROE 37.73%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 26.20x
P/B 22.42x
P/E N/A
Growth
78 /100
Growing Rev. growth 39.49%
Book val. growth 26.58%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 86.26%
FCF margin 29.67%
Net margin 61.95%
Quality
8 /100
Poor ROIC 51.82%
Asset turnover 0.62x
ROE 37.73%
Debt
100 /100
Low Debt/Equity 0.05x
Current ratio 3.40x
Int. coverage N/A
Stability
43 /100
Moderate Beta 0.77x
Profitable years 0
Rev. volatility 72.71%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SPHRY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheryl Maley
Employees
50
Headquarters
Abbotsford
Upcoming events
02 MAR
Earnings
Upcoming earnings report